Masanori Daibata

Title: Masanori Daibata: Innovator in Bacteriophage Therapy

Introduction

Masanori Daibata is a notable inventor based in Kochi, Japan. He has made significant contributions to the field of bacteriophage therapy, particularly in the treatment of bacterial endophthalmitis. His innovative approach aims to provide effective therapeutic solutions for this serious eye condition.

Latest Patents

Masanori Daibata holds a patent for a novel bacteriophage and therapeutic agent specifically designed for treating bacterial endophthalmitis. The patent outlines a therapeutic agent characterized by comprising one or more bacteriophages selected from a specific group, including Myoviridae Spounavirinae phiEF7H, phiEF19G, and phiEF14H1, along with their mutants. This invention represents a significant advancement in the treatment options available for bacterial infections affecting the eye.

Career Highlights

Masanori Daibata is affiliated with Kochi University, where he conducts research and development in the field of bacteriophage therapy. His work has garnered attention for its potential to revolutionize treatment methods for bacterial infections, particularly in ophthalmology.

Collaborations

Masanori Daibata has collaborated with esteemed colleagues such as Ken Fukuda and Shigenobu Matsuzaki. These partnerships have contributed to the advancement of research in bacteriophage therapy and its applications in medical treatments.

Conclusion

Masanori Daibata's contributions to bacteriophage therapy highlight the importance of innovation in addressing medical challenges. His patent for a therapeutic agent for bacterial endophthalmitis showcases the potential of bacteriophages in modern medicine.